Cargando…

Oncolytic Viruses as a Platform for the Treatment of Malignant Brain Tumors

Malignant brain tumors remain incurable diseases. Although much effort has been devoted to improving patient outcome, multiple factors such as the high tumor heterogeneity, the strong tumor-induced immunosuppressive microenvironment, and the low mutational burden make the treatment of these tumors e...

Descripción completa

Detalles Bibliográficos
Autores principales:	de Sostoa, Jana, Dutoit, Valérie, Migliorini, Denis
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589928/ https://www.ncbi.nlm.nih.gov/pubmed/33050329 http://dx.doi.org/10.3390/ijms21207449

Ejemplares similares

Immunotherapy of Malignant Tumors in the Brain: How Different from Other Sites?
por: Dutoit, Valérie, et al.
Publicado: (2016)

Targeting the tumor stroma with an oncolytic adenovirus secreting a fibroblast activation protein-targeted bispecific T-cell engager
por: de Sostoa, Jana, et al.
Publicado: (2019)

Oncolytic Viruses as Therapeutic Tools for Pediatric Brain Tumors
por: Varela-Guruceaga, Maider, et al.
Publicado: (2018)

The Current Landscape of Oncolytic Herpes Simplex Viruses as Novel Therapies for Brain Malignancies
por: Bernstock, Joshua D., et al.
Publicado: (2021)

Oncolytic Viruses for Malignant Glioma: On the Verge of Success?
por: Suryawanshi, Yogesh R., et al.
Publicado: (2021)

Tumor Restrictions to Oncolytic Virus
por: Vähä-Koskela, Markus, et al.
Publicado: (2014)

Oncolytic Viruses: Immunotherapy Drugs for Gastrointestinal Malignant Tumors
por: Li, Qingbo, et al.
Publicado: (2022)

Evidence of Anti-tumoral Efficacy in an Immune Competent Setting with an iRGD-Modified Hyaluronidase-Armed Oncolytic Adenovirus
por: Al-Zaher, Ahmed Abdullah, et al.
Publicado: (2018)

Arming Oncolytic Adenoviruses: Effect of Insertion Site and Splice Acceptor on Transgene Expression and Viral Fitness
por: Farrera-Sal, Martí, et al.
Publicado: (2020)

The Evolution and Future of Targeted Cancer Therapy: From Nanoparticles, Oncolytic Viruses, and Oncolytic Bacteria to the Treatment of Solid Tumors
por: Pierce, Kyle M., et al.
Publicado: (2021)

Allogeneic CAR T Cells: An Alternative to Overcome Challenges of CAR T Cell Therapy in Glioblastoma
por: Martínez Bedoya, Darel, et al.
Publicado: (2021)

Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
por: Everts, Anne, et al.
Publicado: (2020)

Tumor Tropism of DNA Viruses for Oncolytic Virotherapy
por: Enow, Junior A., et al.
Publicado: (2023)

Oncolytic Viruses and Hematological Malignancies: A New Class of Immunotherapy Drugs
por: Innao, Vanessa, et al.
Publicado: (2020)

Progress in oncolytic virotherapy for the treatment of thyroid malignant neoplasm
por: Guan, Mingxu, et al.
Publicado: (2014)

Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
por: Oh, Chang-Myung, et al.
Publicado: (2020)

Beyond Immunotherapy: Seizing the Momentum of Oncolytic Viruses in the Ideal Platform of Skin Cancers
por: Ziogas, Dimitrios C., et al.
Publicado: (2022)

Oncolytic Viruses for Canine Cancer Treatment
por: Sánchez, Diana, et al.
Publicado: (2018)

Remodeling the tumor microenvironment by oncolytic viruses: beyond oncolysis of tumor cells for cancer treatment
por: Wang, Lihong, et al.
Publicado: (2022)

Oncolytic adenoviruses coated with MHC-I tumor epitopes for a new oncolytic vaccine platform
por: Capasso, Cristian, et al.
Publicado: (2015)

Oncolytic Virotherapy for Hematological Malignancies
por: Bais, Swarna, et al.
Publicado: (2012)

Comparison of Clinically Relevant Oncolytic Virus Platforms for Enhancing T Cell Therapy of Solid Tumors
por: Cervera-Carrascon, Victor, et al.
Publicado: (2020)

Editorial: Recent advances in oncolytic virus therapy for brain tumors
por: Askari, Fatemeh Sana, et al.
Publicado: (2023)

Clinical advances in oncolytic virus therapy for malignant glioma: a systematic review
por: Jiang, Shan, et al.
Publicado: (2023)

Oncolytic Viruses in the Treatment of Bladder Cancer
por: Potts, Kyle G., et al.
Publicado: (2012)

Preclinical And Clinical Development Of Oncolytic Adenovirus For The Treatment Of Malignant Glioma
por: Kiyokawa, Juri, et al.
Publicado: (2019)

Oncolytic adenovirus for treatment of malignant ascites
por: Hemminki, Akseli, et al.
Publicado: (2022)

Potential of oncolytic viruses in the treatment of multiple myeloma
por: Bartee, Eric
Publicado: (2018)

The Use of Oncolytic Viruses in the Treatment of Multiple Myeloma
por: Stewart, Georgia, et al.
Publicado: (2021)

Developing Oncolytic Viruses for the Treatment of Cervical Cancer
por: Kalafati, Eleni, et al.
Publicado: (2023)

Oncolytic virus delivery: from nano-pharmacodynamics to enhanced oncolytic effect
por: Yokoda, Raquel, et al.
Publicado: (2017)

Replication and Spread of Oncolytic Herpes Simplex Virus in Solid Tumors
por: Hong, Bangxing, et al.
Publicado: (2022)

Stem Cells Delivered Oncolytic Virus to Destroy Formidable Brain Tumor
por: Balaji E, Vignesh, et al.
Publicado: (2021)

Targeting hematologic malignancies with oncolytic vaccinia virus constructs
por: Chen, Nanhai, et al.
Publicado: (2013)

The potential of swine pseudorabies virus attenuated vaccine for oncolytic therapy against malignant tumors
por: Wang, Guosong, et al.
Publicado: (2023)

Oncolytic virotherapy for pediatric malignancies: future prospects
por: Waters, Alicia M, et al.
Publicado: (2016)

Capitalizing on Cancer Specific Replication: Oncolytic Viruses as a Versatile Platform for the Enhancement of Cancer Immunotherapy Strategies
por: Bastin, Donald, et al.
Publicado: (2016)

Oncolytic Viruses as Platform for Multimodal Cancer Therapeutics: A Promising Land
por: Guo, Z. Sheng, et al.
Publicado: (2014)

Giving Oncolytic Viruses a Free Ride: Carrier Cells for Oncolytic Virotherapy
por: Reale, Alberto, et al.
Publicado: (2021)

Oncolytic viruses for cancer immunotherapy
por: Hemminki, Otto, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_81orpmauck3h8nblvunlchaoeb